Elli Peselev

Array ( [id] => 1496111 [patent_doc_number] => 06403776 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-11 [patent_title] => 'Synthesis of carbamate ketolide antibiotics' [patent_app_type] => B1 [patent_app_number] => 09/610057 [patent_app_country] => US [patent_app_date] => 2000-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30661 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 782 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/403/06403776.pdf [firstpage_image] =>[orig_patent_app_number] => 09610057 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1107954 [patent_doc_number] => 06809091 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-10-26 [patent_title] => 'Substances capable of inducing apoptosis' [patent_app_type] => B1 [patent_app_number] => 09/582554 [patent_app_country] => US [patent_app_date] => 2000-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 23220 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/809/06809091.pdf [firstpage_image] =>[orig_patent_app_number] => 09582554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 979088 [patent_doc_number] => 06930092 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-08-16 [patent_title] => 'Antibiotic agents' [patent_app_type] => utility [patent_app_number] => 10/018467 [patent_app_country] => US [patent_app_date] => 2000-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 23 [patent_no_of_words] => 5513 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/930/06930092.pdf [firstpage_image] =>[orig_patent_app_number] => 10018467 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1504730 [patent_doc_number] => 06465625 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-15 [patent_title] => 'Taxol derivatives' [patent_app_type] => B1 [patent_app_number] => 09/596545 [patent_app_country] => US [patent_app_date] => 2000-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 28 [patent_no_of_words] => 12664 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/465/06465625.pdf [firstpage_image] =>[orig_patent_app_number] => 09596545 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4272492 [patent_doc_number] => 06323182 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-27 [patent_title] => 'Concentrate for medical solution and use thereof' [patent_app_type] => 1 [patent_app_number] => 9/529213 [patent_app_country] => US [patent_app_date] => 2000-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 3983 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/323/06323182.pdf [firstpage_image] =>[orig_patent_app_number] => 529213 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6766118 [patent_doc_number] => 20030100518 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-29 [patent_title] => '13-Methyl erythromycin derivatives' [patent_app_type] => new [patent_app_number] => 09/577901 [patent_app_country] => US [patent_app_date] => 2000-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26258 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20030100518.pdf [firstpage_image] =>[orig_patent_app_number] => 09577901 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4304279 [patent_doc_number] => 06187753 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-13 [patent_title] => 'Psyllium drink mix compositions containing granulated base' [patent_app_type] => 1 [patent_app_number] => 9/570869 [patent_app_country] => US [patent_app_date] => 2000-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3476 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 166 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/187/06187753.pdf [firstpage_image] =>[orig_patent_app_number] => 570869 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1565240 [patent_doc_number] => 06339063 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-15 [patent_title] => '9a-azalides as veterinary antimicrobial agents' [patent_app_type] => B1 [patent_app_number] => 09/508489 [patent_app_country] => US [patent_app_date] => 2000-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2806 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/339/06339063.pdf [firstpage_image] =>[orig_patent_app_number] => 09508489 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1545747 [patent_doc_number] => 06444653 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-03 [patent_title] => 'Glass-like polysaccharide useful as absorbent for liquids' [patent_app_type] => B1 [patent_app_number] => 09/569275 [patent_app_country] => US [patent_app_date] => 2000-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7963 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/444/06444653.pdf [firstpage_image] =>[orig_patent_app_number] => 09569275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1291494 [patent_doc_number] => 06630453 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-07 [patent_title] => 'Androgen derivatives and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/565122 [patent_app_country] => US [patent_app_date] => 2000-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7437 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 406 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/630/06630453.pdf [firstpage_image] =>[orig_patent_app_number] => 09565122 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1037558 [patent_doc_number] => 06872707 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-03-29 [patent_title] => 'Halo derivatives of 9-deoxo-9a-aza-homerythromycin A' [patent_app_type] => utility [patent_app_number] => 09/959662 [patent_app_country] => US [patent_app_date] => 2000-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6287 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/872/06872707.pdf [firstpage_image] =>[orig_patent_app_number] => 09959662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1589918 [patent_doc_number] => 06482943 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-19 [patent_title] => 'Quinones as disease therapies' [patent_app_type] => B1 [patent_app_number] => 09/562980 [patent_app_country] => US [patent_app_date] => 2000-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 29397 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/482/06482943.pdf [firstpage_image] =>[orig_patent_app_number] => 09562980 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5936622 [patent_doc_number] => 20020061857 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-23 [patent_title] => '9-amino-3-oxo erythromycin derivatives' [patent_app_type] => new [patent_app_number] => 09/556645 [patent_app_country] => US [patent_app_date] => 2000-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11230 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20020061857.pdf [firstpage_image] =>[orig_patent_app_number] => 09556645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6131343 [patent_doc_number] => 20020077302 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-20 [patent_title] => 'Tricyclic erythromycin derivatives' [patent_app_type] => new [patent_app_number] => 09/557528 [patent_app_country] => US [patent_app_date] => 2000-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8193 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20020077302.pdf [firstpage_image] =>[orig_patent_app_number] => 09557528 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5936617 [patent_doc_number] => 20020061856 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-23 [patent_title] => 'Novel tricyclic erythromycin derivatives' [patent_app_type] => new [patent_app_number] => 09/556642 [patent_app_country] => US [patent_app_date] => 2000-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7921 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20020061856.pdf [firstpage_image] =>[orig_patent_app_number] => 09556642 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1446810 [patent_doc_number] => 06369035 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-09 [patent_title] => '3,6-hemiketals from the class of 9A-azalides' [patent_app_type] => B1 [patent_app_number] => 09/529642 [patent_app_country] => US [patent_app_date] => 2000-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12763 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 219 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/369/06369035.pdf [firstpage_image] =>[orig_patent_app_number] => 09529642 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7640204 [patent_doc_number] => 06395711 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-28 [patent_title] => 'Macrolides with antitumor activity' [patent_app_type] => B1 [patent_app_number] => 09/485219 [patent_app_country] => US [patent_app_date] => 2000-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 4932 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/395/06395711.pdf [firstpage_image] =>[orig_patent_app_number] => 09485219 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1478517 [patent_doc_number] => 06451768 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-17 [patent_title] => 'Macrolide antiinfective agents' [patent_app_type] => B1 [patent_app_number] => 09/551162 [patent_app_country] => US [patent_app_date] => 2000-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 20091 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/451/06451768.pdf [firstpage_image] =>[orig_patent_app_number] => 09551162 [rel_patent_id] =>[rel_patent_doc_number] =>)